News Release 

Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe COVID-1

JAMA Network Open

What The Study Did: This case series examines whether interleukin 7 (IL-7) is associated with restored host protective immunity in patients with severe COVID-19 and immunosuppression.

Authors: Pierre Francois Laterre, M.D., of the Université Catholique de Louvain in Brussels, Belgium, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2020.16485)

Editor's Note: The article includes funding/support and conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.16485?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=072220

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.